Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Haemodynamic changes in pulmonary hypertension in patients with interstitial lung disease treated with PDE-5 inhibitors.

Zimmermann GS, von Wulffen W, Huppmann P, Meis T, Ihle F, Geiseler J, Leuchte HH, Tufman A, Behr J, Neurohr C.

Respirology. 2014 Jul;19(5):700-6. doi: 10.1111/resp.12294. Epub 2014 Apr 3.

2.

Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease.

Huppmann P, Sczepanski B, Boensch M, Winterkamp S, Schönheit-Kenn U, Neurohr C, Behr J, Kenn K.

Eur Respir J. 2013 Aug;42(2):444-53. doi: 10.1183/09031936.00081512. Epub 2012 Oct 25.

3.

The Munich-LTX-Score: predictor for survival after lung transplantation.

Huppmann P, Neurohr C, Leuschner S, Leuchte H, Baumgartner R, Zimmermann G, Meis T, von Wulffen W, Überfuhr P, Hatz R, Frey L, Behr J; Munich Lung Transplant Group (MLTG).

Clin Transplant. 2012 Jan-Feb;26(1):173-83. doi: 10.1111/j.1399-0012.2011.01573.x. Epub 2011 Dec 20.

PMID:
22188413
4.

Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis?

Neurohr C, Hoffmann AL, Huppmann P, Herrera VA, Ihle F, Leuschner S, von Wulffen W, Meis T, Baezner C, Leuchte H, Baumgartner R, Zimmermann G, Behr J.

Respir Res. 2011 May 21;12:66. doi: 10.1186/1465-9921-12-66.

5.

Effect of inpatient rehabilitation on quality of life and exercise capacity in long-term lung transplant survivors: a prospective, randomized study.

Ihle F, Neurohr C, Huppmann P, Zimmermann G, Leuchte H, Baumgartner R, Kenn K, Sczepanski B, Hatz R, Czerner S, Frey L, Ueberfuhr P, Bittmann I, Behr J; Munich Lung Transplant Group.

J Heart Lung Transplant. 2011 Aug;30(8):912-9. doi: 10.1016/j.healun.2011.02.006. Epub 2011 Apr 13.

PMID:
21489819
6.

Usefulness of exhaled nitric oxide to guide risk stratification for bronchiolitis obliterans syndrome after lung transplantation.

Neurohr C, Huppmann P, Leuschner S, von Wulffen W, Meis T, Leuchte H, Ihle F, Zimmermann G, Baezner C, Hatz R, Winter H, Frey L, Ueberfuhr P, Bittmann I, Behr J; Munich Lung Transplant Group.

Am J Transplant. 2011 Jan;11(1):129-37. doi: 10.1111/j.1600-6143.2010.03327.x. Epub 2010 Nov 18.

7.

Potential functional and survival benefit of double over single lung transplantation for selected patients with idiopathic pulmonary fibrosis.

Neurohr C, Huppmann P, Thum D, Leuschner W, von Wulffen W, Meis T, Leuchte H, Baumgartner R, Zimmermann G, Hatz R, Czerner S, Frey L, Ueberfuhr P, Bittmann I, Behr J; Munich Lung Transplant Group.

Transpl Int. 2010 Sep;23(9):887-96. doi: 10.1111/j.1432-2277.2010.01071.x. Epub 2010 Mar 5.

8.

Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients.

Neurohr C, Huppmann P, Samweber B, Leuschner S, Zimmermann G, Leuchte H, Baumgartner R, Hatz R, Frey L, Ueberfuhr P, Bittmann I, Behr J; Munich Lung Transplant Group.

J Heart Lung Transplant. 2009 May;28(5):468-74. doi: 10.1016/j.healun.2009.01.014. Epub 2009 Mar 14.

PMID:
19416775
9.

Tacrolimus and mycophenolate mofetil as first line immunosuppression after lung transplantation.

Neurohr C, Huppmann P, Zimmermann G, Leuchte H, Baumgartner R, Hatz R, Frey L, Uberfuhr P, Bittmann I, Behr J, Reichart B; Munich Lung Transplant Group.

Transpl Int. 2009 Jun;22(6):635-43. doi: 10.1111/j.1432-2277.2009.00843.x. Epub 2009 Feb 2.

10.

Human herpesvirus 6 in bronchalveolar lavage fluid after lung transplantation: a risk factor for bronchiolitis obliterans syndrome?

Neurohr C, Huppmann P, Leuchte H, Schwaiblmair M, Bittmann I, Jaeger G, Hatz R, Frey L, Uberfuhr P, Reichart B, Behr J; Munich Lung Transplant Group.

Am J Transplant. 2005 Dec;5(12):2982-91.

Supplemental Content

Loading ...
Support Center